MYOS Begins Groundbreaking Clinical Study on Muscle Health; Research Designed to Validate the Strengths of MYO-T12
September 20, 2012 08:29 ET | MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwire - Sep 20, 2012) - MYOS Corporation (OTCBB: MYOS), a company focused on the discovery, development and commercialization of muscle health and performance therapeutic...
Berkeley Research Group Announces Two New Appointments to Healthcare Special Advisory Board
September 19, 2012 08:00 ET | Berkeley Research Group, LLC
EMERYVILLE, CA--(Marketwire - Sep 19, 2012) - Berkeley Research Group, a leading global expert services and consulting firm, has appointed two distinguished physicians to its Healthcare Special...
TuftsCSDD-Logo-Color.jpg
Oncology Drugs Get Faster Approvals Than Non-Oncology Drugs in U.S., but the Opposite Is True in the EU, According to Tufts Center for the Study of Drug Development
September 05, 2012 09:00 ET | Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Sep 5, 2012) - Approval times for new oncology drugs in the United States during the last decade were shorter than approval times for non-oncology products, while the...
TuftsCSDD-Logo-Color.jpg
Drug Companies Are Teaming With Academic Medical Centers to Create New Medicines, According to Tufts Center for the Study of Drug Development
August 07, 2012 09:00 ET | Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Aug 7, 2012) - Drug developers are forging new ways to work with academic medical centers to create the next generation of breakthrough medicines, which is changing the...
TuftsCSDD-Logo-Color.jpg
U.S. Cancer Patients Get Faster Access to More Oncology Drugs Than European Patients, According to Tufts Center for the Study of Drug Development
July 10, 2012 09:00 ET | Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Jul 10, 2012) - Cancer patients in the United States get faster access to more oncology drugs to treat their disease than patients in Europe, according to a newly...
Vista Partners Publishes July 2012 Newsletter
July 03, 2012 09:15 ET | Vista Partners LLC
SAN FRANCISCO, CA--(Marketwire - Jul 3, 2012) - Vista Partners ("Vista") announced today that it published its FREE macroeconomic/small cap oriented monthly newsletter for the month of July. Each...
Clinical Architecture Applauds the HDD Access Initiative, Announces Tool Set Compatibility
May 22, 2012 08:00 ET | Clinical Architecture
CARMEL, IN--(Marketwire - May 22, 2012) - Clinical Architecture today acknowledges the important step forward that HDD Access represents and announces Symedical® Server's ability to provide...
TuftsCSDD-Logo-Color.jpg
Drug Sponsors' Regulatory Experience Was Mixed During PDUFA IV, According to Tufts Center for the Study of Drug Development
May 09, 2012 09:00 ET | Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - May 9, 2012) - Drug sponsors experienced a mixed regulatory burden under the FDA Amendments Act, which was also the fourth iteration of the Prescription Drug User Fee Act...
Tunstall AMAC Announces Dr. Moriah J. Weissman Accepted as Member of ASCO
May 07, 2012 09:30 ET | Tunstall AMAC
NEW YORK, NY--(Marketwire - May 7, 2012) - Tunstall AMAC, a healthcare communication company dedicated to supporting the healthcare community with healthcare communication solutions and advanced...
TuftsCSDD-Logo-Color.jpg
Drug Companies Are Looking to Shorten Time to Early Clinical Development, According to Tufts Center for the Study of Drug Development
April 26, 2012 09:00 ET | Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Apr 26, 2012) - Drug companies looking to increase the efficiency and productivity of their R&D pipelines are turning to a host of techniques and approaches aimed at...